Rosenbaum Faria LLP, Manhattan-based attorneys focused on cancer misdiagnosis and medical malpractice
New York Cancer Lawyer.com - Rosenbaum Faria LLP

home
breast cancer
colorectal cancer
lung cancer
prostate cancer
medical malpractice
contact us
Prostate Cancer Malpractice
Malpractice involving prostate cancer typically involves a failure to diagnose or a failure to treat. Prostate cancer has received a lot of press lately, primarily because it has quickly become the second-most common form of malignant tumor in men. Though potentially deadly, it is easily treatable if detected early.

Some common forms of prostate cancer malpractice include:

  • A failure or delay in referring a patient to see a urologist or arranging tests when displaying symptoms that should have been investigated further
  • A failure or delay in arranging for a biopsy to be carried out when a physical examination reveals an abnormality
  • A failure or delay in reacting to the results of a biopsy or scan
  • Failure to recommend appropriate treatments

Rosenbaum Faria offers free initial consultations and an expert review of your treatment and medical records to assist you in determining whether you or your loved one have been the victim of prostate cancer malpractice.

Many Prostate Cancer Patients Receive Improper Or "Mismatched" Therapies
Prostate cancer patients often receive treatment that is contraindicated by pre-existing conditions, like urinary or bowel dysfunction, according to a new study. Dr. James Talcott of the Massachusetts General Hospital in Boston and co-investigators found that patients with certain pretreatment dysfunctions often receive contraindicated or "mismatched" therapies, which can lead to worse outcomes. more...

Concern Over Standard Treatment For Prostate Cancer
A popular prostate cancer treatment called androgen deprivation therapy may encourage prostate cancer cells to produce a protein that makes them more likely to spread throughout the body, a new study by Johns Hopkins researchers suggests.

Although the finding could eventually lead to changes in this standard treatment for a sometimes deadly disease, the Johns Hopkins researchers caution that their discovery is far too preliminary for prostate cancer patients or physicians to stop using it. The therapy is effective at slowing tumor growth, they emphasized. more...

Rosenbaum Faria, LLP - Cory J. Rosenbaum and Vanessa Faria, attorneys-at-law - Empire State Building - 350 Fifth Avenue, Suite 4400, 44th Floor, New York City, New York 10118
New York Cancer Lawyer.com - Rosenbaum Faria LLP
Copyright 2007 Rosenbaum Faria LLP